Latest News
LegoChemBio Signs License Agreement to Acquire First-in-class Antibody From Elthera
LegoChemBio Signs License Agreement to Acquire First-in-class Antibody From Elthera DAEJEON, South Korea--(BUSINESS WIRE)--LegoChem Biosciences Inc. (KOSDAQ:141080) (hereinafter “LegoChemBio”) announced on February 13, 2023 a license agreement with Elthera AG, a [...]
BIO San Diego
Meet Elthera at BIO Jun 13 - 16, 2022 in San Diego More Info
BIO Europe Spring Digital
Meet Elthera at: BIO-Europe Spring 28th - 31st MARCH 2022 | Digital Conference More Info